AUTL — Autolus Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Autolus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	153	310	382	240	588
Net Total Accounts Receivable
Net Total Receivables	29.7	26.3	29	24.5	48.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	197	347	426	275	661
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	89.7	52.3	58.4	95.7	105
Net Intangible Assets
Other Long Term Assets
Total Assets	294	406	490	375	783
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	33.6	28.6	46.4	44.7	60.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	84.2	92.2	192	264	355
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	210	313	299	111	427
Total Liabilities & Shareholders' Equity	294	406	490	375	783